Doha, Qatar: In an initiative to raise awareness and combat cancer, Qatar Cancer Society (QCS), a non-profit organization that aims to prevent and reduce the burden of cancer in Qatar, and MSD GCC, a leading global pharmaceutical company, have signed a Memorandum of Understanding (MOU), marking the beginning of a collaborative effort to raise awareness about cancer prevention and the importance of early screening. Sheikh Dr. Khalid bin Jabr Al Thani, the Chairman of Qatar Cancer Society, and Ashraf Mallak, the Managing Director of MSD GCC, signed the MOU.
The ceremony was attended by key representatives and decision-makers from various healthcare bodies in Qatar and several media representatives from a diverse array of publications. Their participation not only signifies the importance of the partnership but also highlights the shared commitment to raising awareness and disseminating information about advancements in cancer research and treatment. Commenting on the MoU, Sheikh Dr.
Khalid, Chairman of Qatar Cancer Society, said, “Through strategic partnerships like this one with MSD GCC, Qatar Cancer Society continues its mission to educate and empower communities, contributing to our mission to prevent cancer and reduce its burden in Qatar. Through working with the broader healthcare ecosystem, we aim to support, empower and advocate for people living with the disease, and to engage in professional development and scientific research in the field of cancer,” he stated. He.
